Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

BACKGROUND: Preclinical and preliminary clinical data indicate that ch14.18, a monoclonal antibody against the tumor-associated disialoganglioside GD2, has activity against neuroblastoma and that such activity is enhanced when ch14.18 is combined with granulocyte–macrophage colony-stimulating factor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, London, Wendy B., Kreissman, Susan G., Chen, Helen X., Smith, Malcolm, Anderson, Barry, Villablanca, Judith G., Matthay, Katherine K., Shimada, Hiro, Grupp, Stephan A., Seeger, Robert, Reynolds, C. Patrick, Buxton, Allen, Reisfeld, Ralph A., Gillies, Steven D., Cohn, Susan L., Maris, John M., Sondel, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086629/
https://ncbi.nlm.nih.gov/pubmed/20879881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0911123
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares